BVS – bioventus inc. - class a (US:NASDAQ)
Stock Stats
News
Bioventus Inc. (NYSE: BVS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $7.00 to $8.00. They now have a "buy" rating on the stock.
Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Bioventus Reports First Quarter Financial Results [Yahoo! Finance]
Bioventus Reports First Quarter Financial Results
Osteoarthritis Market Forecast Reveals Significant Growth and Upcoming Therapeutic Advancements by 2032 [Yahoo! Finance]
Form 10-Q Bioventus Inc. For: Mar 30
Form 8-K Bioventus Inc. For: May 07
Form ARS Bioventus Inc. For: Dec 31
Form DEFA14A Bioventus Inc.
Form DEF 14A Bioventus Inc. For: Jun 11
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.